Expansion Therapeutics

Small molecule medicines for RNA-mediated diseases

Jupiter, United States · Founded 2018

Headquarters
Jupiter, Florida
Employees
11–50
Founded
2018
Business Model
B2B
Last Round
Series BSep 2021
Rounds
2

About

Expansion Therapeutics is a clinical-stage biotechnology company focused on developing small molecule therapies for RNA-mediated diseases, particularly repeat expansion disorders such as myotonic dystrophy. The company was co-founded by Matthew Disney and Kevin Forrest and launched with $55.3 million in Series A financing from 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

Summary

Expansion Therapeutics is a Biotech company based in Jupiter, United States, founded in 2018. Its most recent funding was a Series B round in Sep 2021. Investors include Cormorant Asset Management, 5AM Ventures and Kleiner Perkins.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2021

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Expansion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/expansion-therapeutics"><img src="https://indexed.vc/api/badge/company/expansion-therapeutics" alt="Expansion Therapeutics on Indexed.vc" width="260" height="76" /></a>